利用英国初级保健银屑病队列的可解释机器学习方法检测银屑病关节炎:基于临床实践研究数据链的电子健康记录
研究利用英国临床实践研究数据链(CPRD)中1998至2019年122,330例新发银屑病患者电子健康记录,构建贝叶斯网络与随机森林模型检测新发银屑病关节炎(PsA)。最佳贝叶斯网络AUC为0.823、PRAUC为0.221,随机森林AUC为0.851、PRAUC为0.261;银屑病病程、非甾体抗炎药处方、非特异性关节炎、非特异性关节痛和C反应蛋白检测为重要变量。
要点
- 研究纳入122,330例新发银屑病患者,其中2,460例后续发生PsA。
- 最佳贝叶斯网络AUC 0.823、PRAUC 0.221;随机森林AUC 0.851、PRAUC 0.261。
- 银屑病病程、非甾体抗炎药处方、非特异性关节炎、非特异性关节痛和C反应蛋白检测为重要变量。
核心结论
- 研究能够在英国初级保健中识别银屑病患者中PsA风险较高者及重要指标,进一步工作需评估模型辅助PsA筛查的实用性。
研究设计与样本
- 利用英国临床实践研究数据链(CPRD)的初级保健电子健康记录,构建贝叶斯网络与随机森林模型。
- 研究人群为无PsA的新发银屑病患者队列,前瞻性随访,使用诊断前测量的初级保健变量建模。
- 变量包括患者人口学特征、肌肉骨骼症状、血液检测和处方;采用置换变量重要性评估各变量重要性。
- 模型区分度以受试者工作特征曲线下面积(AUC)和精确率-召回率曲线下面积(PRAUC)衡量。
主要发现
- 1998至2019年间在CPRD中识别122,330例新发银屑病患者,其中2,460例后续发生PsA。
- 最佳贝叶斯网络AUC为0.823、PRAUC为0.221,随机森林AUC为0.851、PRAUC为0.261。
- 银屑病病程、非甾体抗炎药处方、非特异性关节炎、非特异性关节痛和C反应蛋白血液检测在模型中均为重要变量。
临床怎么用
- 原文结论指出研究识别了英国初级保健中银屑病患者中PsA风险较高者及重要指标,并指出需进一步工作评估模型辅助PsA筛查的实用性。
局限性
- 原文结论指出需进一步工作评估模型辅助PsA筛查的实用性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Develop an interpretable machine learning model to detect patients with newly diagnosed psoriatic arthritis (PsA) in a cohort of psoriasis patients and identify important clinical indicators of PsA in primary care. METHODS: We developed models using UK primary care electronic health records from the Clinical Practice Research Datalink (CPRD). The study population consisted of a cohort of (PsA free) patients with incident psoriasis who were followed prospectively. We used Bayesian networks (BNs) to identify patients who developed PsA using primary care variables measured prior to diagnosis and compared the results to a random forest (RF). Variables included patient demographics, musculoskeletal symptoms, blood tests, and prescriptions. The importance of each variable used in the models was evaluated using permutation variable importance. Model discrimination was measured using the area under the receiver operating characteristic curve (AUC) and the area under the precision-recall curve (PRAUC). RESULTS: We identified a cohort of 122,330 patients with an incident psoriasis diagnosis between 1998 and 2019 in the CPRD, of whom 2460 patients went on to develop PsA. Our best BN achieved an AUC of 0.823, and PRAUC of 0.221, compared to the AUC of 0.851 and PRAUC of 0.261 of the RF. Psoriasis duration, nonsteroidal anti-inflammatory drug prescriptions, nonspecific arthritis, nonspecific arthralgia, and C-reactive protein blood tests were all important variables in our models. CONCLUSIONS: We were able to identify psoriasis patients at higher risk, and important indicators, of PsA in UK primary care. Further work is required to evaluate our model's usefulness in assisting PsA screening.
引用
- Rudge A, McHugh N, Tillett W, et al. An interpretable machine learning approach for detecting psoriatic arthritis in a UK primary care psoriasis cohort using electronic health records from the Clinical Practice Research Datalink. Ann Rheum Dis. 2025. PMID: 40024862. doi:10.1016/j.ard.2025.01.051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。